Last updated on October 2013

Alliance A031203: Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) With Commercially Supplied Sunitinib in Patients With Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma


Brief description of study

Alliance A031203: Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) With Commercially Supplied Sunitinib in Patients With Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma

Detailed Study Description

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01835158?term=A031203&rank=1

Clinical Study Identifier: TX137257

Find a site near you

Start Over

Memorial Health University Medical Center

4700 Waters Avenue Hoskins Center - 2nd Floor Savannah, GA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.